About BMJ Group media relations team (Emma Dickinson, Caroline White, and Erin Barton)

Our media relations team connects journalists with expert insights and the latest research to support accurate, evidence based healthcare reporting. They manage media interviews, press releases, media inquiries, and publicise key findings from the Group's journals, tools, and services. Contact: mediarelations@bmj.com or +44 (0)7825 118 107

Women still missing out on treatment for their No 1 killer—cardiovascular disease

Despite major progress in disease management, they are underdiagnosed and undertreated Dedicated heart champions, hubs, and health strategy among key actions needed Women in the UK, and elsewhere, are still missing out on vital treatment for their No 1 killer—cardiovascular disease—despite significant progress in the medical management of heart disease ...

2025-06-26T10:57:03+00:0025 September 2024|Heart, Press release|

Global prevalence of short-sightedness in children and teens set to top 740 million cases by 2050

Condition currently affects estimated third of children and teens around the world Female sex, East Asian or urban area residence, and educational level influential factors Around 1 in 3 children and teens around the world is short (near)-sighted, with the global prevalence of myopia set to top 740 million cases ...

2024-09-25T12:12:03+00:0025 September 2024|British Journal of Ophthalmology, Press release|

Triptans more effective than newer, more expensive migraine drugs

The most effective triptans should be promoted globally and guidelines updated accordingly, say researchers Some triptans are a more effective treatment for acute migraines than newer, more expensive drugs, finds an analysis of the latest evidence published by The BMJ today. Triptans work by narrowing blood vessels in the brain and preventing ...

2024-09-19T09:16:05+00:0019 September 2024|Press release, The BMJ|

No major concerns about risks to offspring for would-be dads taking epilepsy meds

Evidence on antiseizure drugs is inconsistent; but most studies show no heightened risk Findings cast doubt cast on stance taken by UK drugs regulator, say authors Would-be dads taking drugs to stop their epilepsy seizures—and valproate in particular—should be largely reassured that the available evidence on the developmental risks to ...

Shorter-course radiation better option for breast cancer patients than conventional schedule

Although survival and recurrence were similar, this approach is safer, more convenient for patients, and less costly, say researchers Giving higher doses per fraction of radiation therapy over a shorter time after breast cancer surgery significantly reduces the risk of side effects and improves quality of life compared with a ...

2024-09-12T15:18:21+00:0012 September 2024|Press release, The BMJ|

One dose of smallpox vaccine moderately effective in preventing mpox infection

Vaccine should be made available to communities at risk, say researchers One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox infection and should be made available to communities at risk, finds a study published by The BMJ today. With mpox infections rising again across the ...

2024-09-12T15:15:58+00:0012 September 2024|Press release, The BMJ|
Go to Top